2-Methylthiazole-4-carboximidamide
CAS : 18876-81-8
Ref. 3D-TAA87681
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
2-Methylthiazole-4-carboximidamide
Description :
2-Methylthiazole-4-carboximidamide is a drug that inhibits the activity of hydroxylases, which are enzymes involved in the production of certain proteins. It is used to treat erythropoiesis problems, such as anemia and thalassemia. 2-Methylthiazole-4-carboximidamide has been shown to be effective in clinical trials involving human subjects with hematological disorders. The drug is taken orally and binds to hemoglobin, which decreases the number of reticulocytes and leads to increased hemoglobin levels. 2-Methylthiazole-4-carboximidamide was developed by medicinal chemists as an optimization process for the treatment of erythropoietic diseases.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
141.2 g/mol
Formule :
C5H7N3S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
